Mesoblast Limited
MESO
$16.14
-$0.25-1.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 56.83% | 0.00% | 25.91% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -0.77% | 0.00% | -0.23% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -76.16% | 0.00% | 0.41% | 0.00% |
| Change in Net Operating Assets | 0.00% | 66.42% | 0.00% | -572.25% | 0.00% |
| Cash from Operations | 0.00% | 55.56% | 0.00% | -3.57% | 0.00% |
| Capital Expenditure | 0.00% | 2.61% | 0.00% | 26.48% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 97.30% | 0.00% | -376.12% | 0.00% |
| Cash from Investing | 0.00% | 31.47% | 0.00% | -19.72% | 0.00% |
| Total Debt Issued | 0.00% | -29.93% | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 19.39% | 0.00% | -1,039.31% | 0.00% |
| Issuance of Common Stock | 0.00% | -14.75% | 0.00% | -96.64% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -60.47% | 0.00% | -4.12% | 0.00% |
| Cash from Financing | 0.00% | -1,158.95% | 0.00% | -100.74% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 107.16% | 0.00% | -70.89% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 14.30% | 0.00% | -125.56% | 0.00% |